This regular update (no. 84 | 17 May 2022 ) covers key regulatory EU developments related to the evolving COVID-19 situation (Antitrust & State Aid; Trade/Export Controls; Medicines, Medical Devices and Personal Protective Equipment; and Cybersecurity, Privacy & Data Protection).

LATEST KEY DEVELOPMENTS

Competition & State Aid

  • European Commission to phase out State aid COVID Temporary Framework
  • European Commission approves new and amended Member State measures to support the economy
  • European Commission approves further schemes under State aid Temporary Crisis Framework in context of Russia's invasion of Ukraine

Trade / Export Controls

  • EU-US Trade and Technology Council issue Joint Statement following second ministerial-level meeting
  • Affirmed commitment to US-EU Agenda for Beating the Global Pandemic

Medicines and Medical Devices

  • EMA endorses Joint Statement for healthcare professionals: How COVID-19 vaccines are regulated for safety and effectiveness
  • European Commission announces agreement with BioNTech and Pfizer on delivery of COVID-19 vaccines

Cybersecurity, Privacy & Data Protection

  • European Parliament and Council provisionally agree on proposed Directive for high common level of cybersecurity across the Union
  • European Commission proposes Regulation on European Health Data Space

Attachments: COVID19 KEY EU DEVELOPMENTS No 84 17 May 2022

Originally published May 2022

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.